A detailed history of Longbow Finance Sa transactions in Abb Vie Inc. stock. As of the latest transaction made, Longbow Finance Sa holds 37,405 shares of ABBV stock, worth $6.28 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
37,405
Previous 28,764 30.04%
Holding current value
$6.28 Million
Previous $4.93 Billion 49.72%
% of portfolio
0.79%
Previous 0.51%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $1.42 Million - $1.72 Million
8,641 Added 30.04%
37,405 $7.39 Billion
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $238,995 - $279,093
-1,544 Reduced 5.09%
28,764 $4.93 Billion
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $4.84 Million - $5.52 Million
30,308 New
30,308 $5.52 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Longbow Finance Sa Portfolio

Follow Longbow Finance Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longbow Finance Sa, based on Form 13F filings with the SEC.

News

Stay updated on Longbow Finance Sa with notifications on news.